Pittenger & Anderson Inc. raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 1.1% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 60,142 shares of the medical equipment provider's stock after purchasing an additional 651 shares during the quarter. Intuitive Surgical accounts for about 1.1% of Pittenger & Anderson Inc.'s portfolio, making the stock its 19th largest position. Pittenger & Anderson Inc.'s holdings in Intuitive Surgical were worth $29,787,000 as of its most recent SEC filing.
Other institutional investors have also recently made changes to their positions in the company. Atala Financial Inc acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at $25,000. Hurley Capital LLC purchased a new position in Intuitive Surgical during the 4th quarter worth $28,000. Parvin Asset Management LLC acquired a new stake in Intuitive Surgical in the 4th quarter valued at about $26,000. Chilton Capital Management LLC boosted its stake in shares of Intuitive Surgical by 614.3% during the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock worth $25,000 after purchasing an additional 43 shares during the last quarter. Finally, Global Financial Private Client LLC raised its holdings in Intuitive Surgical by 253.3% in the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock valued at $26,000 after buying an additional 38 shares during the period. Institutional investors own 83.64% of the company's stock.
Insider Activity
In other news, EVP Robert Desantis sold 188 shares of Intuitive Surgical stock in a transaction dated Monday, April 28th. The shares were sold at an average price of $515.91, for a total value of $96,991.08. Following the sale, the executive vice president owned 5,224 shares of the company's stock, valued at $2,695,113.84. The trade was a 3.47% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Gary Loeb sold 1,700 shares of the stock in a transaction on Friday, April 25th. The stock was sold at an average price of $513.18, for a total transaction of $872,406.00. Following the completion of the sale, the executive vice president directly owned 2,245 shares of the company's stock, valued at $1,152,089.10. The trade was a 43.09% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 4,998 shares of company stock valued at $2,611,577. Company insiders own 0.70% of the company's stock.
Wall Street Analysts Forecast Growth
A number of research firms have issued reports on ISRG. Barclays cut their target price on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a research note on Thursday, April 24th. BTIG Research set a $560.00 target price on Intuitive Surgical and gave the stock a "buy" rating in a report on Monday, April 14th. Evercore ISI increased their target price on Intuitive Surgical from $470.00 to $550.00 and gave the company an "in-line" rating in a research note on Tuesday, July 8th. Royal Bank Of Canada decreased their price target on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a research note on Wednesday, April 23rd. Finally, Erste Group Bank raised Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Thursday, June 5th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the company's stock. Based on data from MarketBeat.com, Intuitive Surgical currently has an average rating of "Moderate Buy" and a consensus target price of $592.59.
Check Out Our Latest Analysis on ISRG
Intuitive Surgical Stock Up 1.3%
Shares of ISRG stock traded up $6.66 during trading hours on Monday, hitting $518.72. 600,507 shares of the company's stock traded hands, compared to its average volume of 1,678,211. The stock's fifty day simple moving average is $537.85 and its two-hundred day simple moving average is $536.67. Intuitive Surgical, Inc. has a 12-month low of $413.82 and a 12-month high of $616.00. The stock has a market cap of $185.92 billion, a price-to-earnings ratio of 76.06, a PEG ratio of 5.43 and a beta of 1.64.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. The firm had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. During the same period last year, the firm earned $1.50 earnings per share. On average, equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.
Intuitive Surgical Profile
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Read More

Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.